Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3386-3393

  Yachida, Shinichi ^a,d   Imaida, Katsumi ^b   Yokohira, Masanao ^b   Hashimoto, Nozomi ^a,b   Suzuki, Shugo ^c   Okano, Keiichi ^a   Wakabayashi, Hisao ^a   Maeta, Hajime ^a   Suzuki, Yasuyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEPTIDE HYDROLASES; PRECANCEROUS CONDITIONS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 78650990591     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1197-7     Document Type: Article

References (47)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385
2. M Sakamoto S Hirohashi Y Shimosato 1991 Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma Human Pathol. 22 172 178 1:STN:280:DyaK3M7mtFWmsg%3D%3D
3. M Sakamoto S Hirohashi 1998 Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection Jpn J Clin Oncol. 28 604 608 1:STN:280:DyaK1M%2Fltlagtw%3D%3D 9839500
4. T Oikawa H Ojima S Yamasaki T Takayama S Hirohashi M Sakamoto 2005 Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules J Hepatol. 42 225 229 15664248
5. T Takayama M Makuuchi S Hirohashi, et al. 1990 Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma Lancet. 336 1150 1153 1:STN:280:DyaK3M%2FktFaktg%3D%3D 1978027
6. T Takayama M Makuuchi M Kojiro, et al. 2008 Early hepatocellular carcinoma: pathology, imaging, and therapy Ann Surg Oncol. 15 972 978 18236118
7. Hirohashi S, Ishak KG, Kojiro M, et al. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press, 2000:159-72.
8. Y Morimitsu CC Hsia M Kojiro E Tabor 1995 Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: reactive expression of transforming growth factor-alpha and its receptor in the different areas of tumor Human Pathol. 26 1126 1132 1:CAS:528:DyaK2MXpsVWjsLY%3D
9. Kip1 is heplo-insufficient for tumor suppression Nature. 396 177 180 1:CAS:528:DyaK1cXnslartLs%3D 9823898
10. MH Lee I Reynisdottir J Massagué 1995 Cloning of p57KIP2, A cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev. 9 639 649 1:CAS:528:DyaK2MXltVWqs7g%3D 7729683
11. K Polyak MH Lee H Erdjument-Bromage A Koff JM Roberts P Tempst J Massagué 1994 Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell. 78 59 66 1:CAS:528:DyaK2cXlvF2hsb0%3D 8033212
12. Kip1 is overexpressed in very early stages of hepatocarcinogenesis Cancer Sci. 99 2152 2159 1:CAS:528:DC%2BD1cXhsVKgtLrL 18808421
13. AC Carrano E Eytan A Hershko M Pagano 1999 Skp2 is required for ubiquitin-mediated degradation of Cdk inhibitor p27 Nat Cell Biol. 1 193 197 1:CAS:528:DyaK1MXltlSjtr0%3D 10559916
14. Kip1 degradation and induces S phase in quiescent cells Nat Cell Biol. 1 207 214 10559918
15. Kip1 is instigated by Jab1 Nature. 398 160 165 1:CAS:528:DyaK1MXhvFKisLc%3D 10086358
16. Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex J Biol Chem. 277 2302 2310 1:CAS:528:DC%2BD38XosFersw%3D%3D 11704659
17. N Wei XW Deng 2003 The COP9 signalosome Annu Rev Cell Dev Biol. 19 261 286 1:CAS:528:DC%2BD3sXpsFamt78%3D 14570571
18. DA Chamovitz D Segal 2001 JAB1/CSN5 and the COP9 signalosome. A complex situation EMBO Rep. 2 96 101 1:CAS:528:DC%2BD3MXks1Cqu7w%3D 11258719
19. KIP1 and poor prognosis in oral squamous cell carcinomas Oncology. 65 355 362 1:CAS:528:DC%2BD2cXhtV2ruw%3D%3D 14707456
20. Kip1 Cancer Res. 63 2977 2981 1:CAS:528:DC%2BD3sXkt1aitb4%3D 12782606
21. F Wang Y Wang X Yu, et al. 2009 Significance of Jab1 expression in human esophageal squamous cell carcinoma J Clin Gastroenterol. 43 520 526 1:CAS:528:DC%2BD1MXnsFyhsb4%3D 19349901
22. A Goto T Niki S Moriyama, et al. 2004 Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of p27, in lung adenocarcinoma Pathol Int. 54 675 681 1:CAS:528:DC%2BD2cXpt1ajuro%3D 15363035
23. Y Dong L Sui Y Watanabe F Yamaguchi N Hatano M Tokuda 2005 Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas Clin Cancer Res. 11 259 266 1:CAS:528:DC%2BD2MXhtVegsbk%3D 15671554
24. A Osoegawa I Yoshino T Kometani M Yamaguchi T Kameyama T Yohena Y Maehara 2006 Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features Cancer. 107 154 161 1:CAS:528:DC%2BD28XntVylsrk%3D 16721818
25. kip1 in pancreatic adenocarcinoma Cancer Res. 66 8581 8589 1:CAS:528:DC%2BD28XovF2itLs%3D 16951171
26. Kip1 and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas Ann Surg Oncol. 16 395 403 19034576
27. MA Patil I Gütgemann J Zhang, et al. 2005 Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis. 26 2050 2057 1:CAS:528:DC%2BD2MXht1ent7fE 16000397
28. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. Tokyo: Kanehara, 2003.
29. Y Ito N Matsuura M Sakon, et al. 1999 Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence Hepatology. 30 90 99 1:STN:280:DyaK1MzhsFOnsA%3D%3D 10385644
30. A Tannapfel D Grund A Katalinic, et al. 2000 Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma Int J Cancer. 89 350 355 1:CAS:528:DC%2BD3cXlvFagsbs%3D 10956409
31. M Fiorentino A Altimari A D'Errico B Cukor C Barozzi M Loda WF Grigioni 2000 Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma Clin Cancer Res. 6 3966 3972 1:CAS:528: DC%2BD3cXotVykurw%3D 11051245
32. Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma J Hepatol. 38 591 597 1:CAS:528: DC%2BD3sXjtFert7o%3D 12713869
33. M Chuma M Sakamoto K Yamazaki T Ohta M Ohki M Asaka S Hirohashi 2003 Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma Hepatology. 37 198 207 1:CAS:528:DC%2BD3sXovVWhuw%3D%3D 12500205
34. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer Nat Med. 8 1136 1144 1:CAS:528:DC%2BD38XnsVGrt7g%3D 12244303
35. Kip1 at threonine 157 and modulation of its cellular localization Nat Med. 8 1145 1152 1:CAS:528:DC%2BD38XnsVGrt70%3D 12244301
36. J Liang J Zubovitz T Petrocelli, et al. 2002 PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat Med. 8 1153 1160 1:CAS:528:DC%2BD38XnsVGrt7s%3D 12244302
37. T Takami S Terai Y Yokoyama, et al. 2005 Human homologue of maid is a useful marker protein in hepatocarcinogenesis Gastroenterology. 128 1369 1380 1:CAS:528:DC%2BD2MXlt1Cis7k%3D 15887118
38. Kip1: influence on proliferation in hepatocellular carcinoma Hum Pathol. 38 1621 1627 1:CAS:528:DC%2BD2sXhtF2lsb3I 17651785
39. MC Hsu CC Huang HC Chang TH Hu WC Hung 2008 Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor γ ligands in vitro and in vivo Clin Cancer Res. 14 4045 4052 1:CAS:528:DC%2BD1cXnvFylurw%3D 18593980
40. E Bianchi S Denti A Granata, et al. 2000 Integrin LFA-1 Interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity Nature. 404 617 621 1:CAS:528:DC%2BD3cXis1Grsbw%3D 10766246
41. R Kleemann A Hausser G Geiger, et al. 2000 Intracelluar action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 Nature. 408 211 216 1:CAS:528:DC%2BD3cXotFGlt74%3D 11089976
42. GA Cope GS Suh L Aravind SE Schwarz SL Zipursky EV Koonin RJ Deshales 2002 Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1 Science. 298 608 611 1:CAS:528:DC%2BD38XnvFSqur0%3D 12183637
43. D Bech-Otschir R Kraft X Huang P Henklein B Kapelari C Pollmann W Dubiel 2001 COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system EMBO J. 20 1630 1639 1:CAS:528:DC%2BD3MXivVCrsr8%3D 11285227
44. R Eferl R Ricci L Kenner R Zenz JP David M Rath EF Wagner 2003 Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 Cell. 112 181 192 1:CAS:528:DC%2BD3sXpvVemsA%3D%3D 12553907
45. M Wan X Cao Y Wu, et al. 2002 Jab1 Antagonizes TGF-beta signaling by inducing Smad4 degradation EMBO Rep. 3 171 176 1:CAS:528:DC%2BD38XitVGqtrs%3D 11818334
46. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshai K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 2010 (in press).
47. Y Tanaka F Kanai T Ichimura, et al. 2006 The Hepatitis B Virus X 'rotein Enhances AP-1 Activation through Interaction with Jab1 Oncogene 25 633 642 1:CAS:528:DC%2BD28XnsFSjtw%3D%3D 16247477